Contact person: Antal Lopata
The Symposium on Medicinal Chemistry in Eastern England, known colloquially as the "Hatfield MedChem" meeting, is a highly successful, long-standing, one-day meeting which runs annually. The scientific programme will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics from the forefront of drug discovery of relevance to medicinal chemists. The meeting will aim to be informal and interactive and the event offer excellent scientific and networking opportunities for all those working in medicinal chemistry and drug discovery.
Contact person: Mrs Maggi Churchouse
Tel: +44 (0)1359 221004
The ‘SCS Conference on Stereochemistry’, better known as ‘Bürgenstock Conference’, is an outstanding international chemistry meeting of high scientific quality, with an optimal setting for intense inter-disciplinary discussion.
Stereochemistry is the principle underlying our understanding of the processes of life and the properties of matter at the molecular level. It is a key element not only in all chemical disciplines, but also in modern molecular biology, molecular medicine, biophysics, and material design. Accordingly, the ‘Bürgenstock Conference’ has grown over the years into a multi-disciplinary conference where frontier science is being discussed. Lectures cover many areas of chemistry and relevant highlights from neighboring disciplines.
According to its long tradition, the 54th Bürgenstock Conference 2019 will again be interdisciplinary, covering many areas of chemistry in its main body, but allowing also for relevant highlights from neighboring disciplines, with due focus on structural and mechanistic aspects in all contributions.
For more information please contact:
The Academic Drug Discovery Consortium invites you to hear about the latest ideas in small-molecule library development at, Better Leads, Better Drugs: Innovations in Screening Libraries.
Scientists engaged in drug discovery and chemical biology know that a screen is only as good as the molecules that go into it. But with the vast potential chemical space, how do you decide what to include in your virtual, high-throughput, or fragment-based screens? This event will bring together drug-seekers from academia and industry focused on the application of new technologies and computational tools to tackle this question in order to deliver higher quality leads.
- Yun Ding, GlaxoSmithKline, United States
- Lori Ferrins, Northeastern University, United States
- John Irwin, UCSF Pharmaceutical Chemistry, United States
- Ajit Jadav, NIH/NCATS, United States
- Jeremy Jenkins, Novartis Institute of Biomedical Sciences, United States
- Stephen LaPlante, University of Quebec, Visiting professor at Broad Institute, Canada
Registration Deadline: April 1, 2019
For more information please contact Jayshree Mistry ( )
Contact person: Jelka Dolinar MPharm
Tel: +386 1 569 26 01
Fax: +386 1 569 26 02
The meeting is directed at individuals with a curiosity into what Flow is and how it may benefit them or their organisations, and those already involved in the area. The presentations will cover aspects from microfluidics discovery to production scale manufacture, highlighting the latest developments, novel methods, engineering and their application. This meeting will be of particular interest to synthetic chemists, process development chemists, chemical engineers and plant managers operating in pharmaceutical, agrochemicals and the fine and speciality chemicals industries.
Themes and topics
- Research and Discovery
- Flow Technology for molecule makers
- Process Development and Scale up
- The Interface of chemistry and engineering
- Commercial Manufacture
- Industrial applications and further challenges
- Prof. Ian Baxendale, Durham University, UK
- Prof. Klavs Jensen, Massachusetts Institute of Technology, USA
- Prof. Oliver Kappe, Karl-Franzens University Graz, Austria
- Prof. Tyler McQuade, Virginia Commonwealth University, USA
Contact person: Mrs Maggi Churchouse
Tel: +44 (0)1359 221004
2nd Molecules Medicinal Chemistry Symposium - Facing Novel Challenges in Drug Discovery
EFMC Sponsored Event
The conference is organized by MDPI, the publisher of the open-access journal Molecules and follows the very successful one-day meeting,"Molecules Medicinal Chemistry Symposium (MMCS): Emerging Drug Discovery Approaches against Infectious Diseases", held in September 2017 at the School of Pharmacy and Food Sciences of the University of Barcelona, Spain, which turned out to be a very fruitful forum for discussion on the specific topic of anti-infective drug discovery, in an excellent atmosphere created by the more than 70 attendees from 20 countries.
Encouraged by the great success of the initial small-format monographic MMCS2017, the three-day MMCS2019 will grow naturally by addressing a larger audience and essentially all topics of medicinal chemistry. The MMCS2019 will be organized into a number of thematic sessions on medicinal chemistry of particularly challenging diseases, novel and revisited drug discovery approaches, and medicinal chemistry stories about recently implemented projects in any area not covered in the other sessions, from target and hit identification to hit-to-lead optimization, tuning of physicochemical and pharmacokinetic properties, preclinical and clinical development, etc.
Two prominent and inspiring keynote speakers per session will share the program with a number of selected oral communications, especially by young researchers. The program will be complemented by poster presentations, and social events on the second day of the conference.
- Prof. Xavier Barril (University of Barcelona, Spain)
- Prof. Dr Alessio Ciulli (University of Dundee, United Kingdom)
- Prof. Dr Rebecca Deprez-Poulain (University of Lille, France)
- Dr Eva Estébanez-Perpiñá (University of Barcelona, Spain)
- Prof. Dr Christa E. Müller (University of Bonn, Germany)
- Prof. Dr Stephen Neidle (University College London, United Kingdom)
- Prof. Dr Barry V. L. Potter (University of Oxford, United Kingdom)
- Prof. Dr Jörg Rademann (Free University of Berlin, Germany)
- Prof. Dr Yi Sun (University of Michigan, United States and Zhejiang University, China)
- Prof. Dr Santiago Vázquez (University of Barcelona, Spain)
- Prof. Dr Mark von Itzstein (Griffith University, Australia)
Deadline to submit your abstract is January 10, 2019
Deadline for early bird registration is March 8, 2019
Contact: George Andrianou
This scientific event will provide high-level lectures, communications and poster presentations held by histamine experts. The Meeting will also be a good opportunity to broaden your knowledge, establish new scientific cooperation and meet colleagues personally.
Conference main topics
- Pain, neuropathic pain
- Pruritus, urticaria, allergy, asthma and food allergy
- Multitarget, multifunctional approaches for complex diseases
- Around histamine, development of new biologically active compounds
- Histamine in gastrointestinal tract
- Inflammation and postinflammatory hypersensitivity
- Histamine production by commensal bacteria
- CNS, neuroprotection, neuroinflammation, neurodegenerative diseases
Contact person: Assoc. Prof. Ewa Szymanska
Tel: +48 12 620 55 80
Fax: +48 12 620 55 96